Pharmaceutical Litigation for Genital Infections from Diabetes Drugs
The popular diabetes drugs in the SGLT2 inhibitor class have been found to cause a severe genital infection that can lead to permanent disfigurement and cause a host of life-threatening conditions. The rare bacterial infection, which doctors call necrotizing fasciitis and is also referred to as Fournier’s gangrene, was linked to diabetes drugs in a 2018 FDA diabetes drug warning. In the past 30 years, the FDA has recorded only six cases of this severe flesh-eating genital infection, affecting only men. The FDA diabetes drug infection warning was prompted by 12 cases of Fournier’s gangrene in the past five years, in both men and women taking glucose-regulating diabetes drugs. Among these twelve documented cases of diabetes patients developing necrotizing fasciitis from SGLT2 inhibitors, each has required surgery, many have been left permanently disfigured, and one died of complications.
FDA diabetes drug infection warning encompasses nearly all SGLT2 inhibiting diabetes drugs, a class of drugs that is rapidly growing in use worldwide. During 2017, 1.7 million Americans filled a prescription for one of these drugs, and Bloomberg estimates the market for these diabetes drugs will climb to $7 billion by 2020. The companies vying for market shares in this competitive arena are major players on the global scale, including Janssen (a subsidiary of Johnson & Johnson), AstraZeneca, Merck, and Boehringer Ingelheim (a subsidiary of Eli Lilly).
From billions paid for criminal fines (Eli Lilly) to billions paid in settlements to victims of talcum powder cancer (Johnson & Johnson), each of these companies has proven it will prioritize profits over consumer safety. Individual consumers who have been harmed by severe genital infections are filing diabetes drug infection lawsuits to hold drugmakers accountable and obtain the compensation they deserve for suffering, harm, medical expenses, and loss related to necrotizing fasciitis from diabetes medications. Our attorneys handling diabetes drug infections lawsuit claims believe persons and family members of persons having suffered from Fournier’s gangrene may be entitled to significant compensation and are offering free case reviews to anyone who believes they may qualify.
Flesh-eating Genital Infection
A 2018 FDA Diabetes Drug Infection Warning was the first information consumers received on the risk of severe genital infections from SGLT2 inhibitors. Persons suffering from Type 2 diabetes commonly are prescribed these drugs as a glucose-regulator. In essence, they are taking the drug to resolve a life-threatening health problem only to be exposed to a risk for a severe genital infection that can result in permanent disfigurement and death. Known as Fournier’s gangrene or necrotizing fasciitis, this flesh-eating genital infection is linked to the following diabetes medications: canagliflozin (Invokana, Invokamet, Invokamet XR), dapagliflozin (Farxiga, Xigduo XR, Qtern), empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR), and ertugliflozinv (Steglatro, Segluromet, Stelujan). Read full diabetes drug genital infection information.
Necrotizing fasciitis or Fournier’s gangrene is a severe and rare genital infection caused by certain Type 2 diabetes drugs. This bacterial infection affects the areas of the body surrounding the genitals and perineum, destroying any tissue it comes into contact with. Patients who develop Fournier’s gangrene require surgery, may experience permanent disfigurement, and can develop further health conditions such as diabetic ketoacidosis, acute kidney injury, and septic shock. Persons and family members of persons who developed necrotizing fasciitis while taking diabetes medications may be eligible for compensation through filing a diabetes drug infection lawsuit against manufacturers Eli Lilly/ Boehringer Ingelheim, AstraZeneca, Merck, and Janssen/J&J. Read full necrotizing fasciitis information.
Diabetes Drug infection Lawsuits
Any person, or family member of a person, who has suffered from a severe genital infection while taking glucose-controlling drugs for Type 2 diabetes, may be eligible for compensation by filing a diabetes drug infection lawsuit. Necrotizing fasciitis is a severe genital infection that destroys any flesh it infects and can lead to life-threatening complications. Our attorneys handling national diabetes drug infection lawsuit claims are now offering free, no-obligation case reviews to help you determine whether you may have grounds for a case. Read full diabetes drug infection lawsuit information from attorneys handling claims from plaintiffs nationwide.
Diabetes Drug Infection Lawsuit FAQ
Our attorneys handling diabetes drug infection lawsuit claims have compiled answers to the most common questions we receive. This information contained on this page will be applicable to many general questions regarding diabetes drug infection lawsuits against for necrotizing fasciitis. Our drug safety attorneys are offering free, no-obligation case consultation to persons who have suffered from severe genital infections from diabetes medications. Read full diabetes drug genital infection lawsuit questions and answers.
Diabetes Drug Infection Lawyers
Our diabetes drug infection attorneys are seasoned consumer safety lawyers with a distinguished track record of success. Winning major cases on behalf individuals and families harmed by dangerous drugs, our diabetes genital infection lawyers know how to bring multinational pharmaceutical giants to justice. Our attorneys handling diabetes genital infection claims help individuals and families recover the compensation they need and deserve, while holding companies accountable for consumer safety. Read full information for filing a diabetes drug infection claim against Eli Lilly/ Boehringer Ingelheim, AstraZeneca, Merck, and Janssen/J&J.